Table 5 The eligible sites for conducting the diabetes TRANSFoRm use-cases
PairNameCountryURLSize (N/1000)Date establishedPrimary coding systemSecondary coding systemLinkage Yes/Pilot/Plan/NoEthics approvalContact patients
MonthsY/N
Primary Care & Genetic ‘Biobanks’
1Biobank of Medical University GrazAustriawww.medunigraz.at/biobank100–10002006ICD-10n/aPilot≤3 monthsYes
Austrian Primary Care Research NetworkAustrian/a10–1002005ICPC-2n/aNo≤3 monthsNo
2GénéthonFrancewww.genethon.fr10–1001991n/an/aPilot4–6 monthsYes
OMG CONSTANCE GAZELFrance0.1–1n/aNo
3Da Vinci European Biobank (daVEB)Italywww.davincieuropeanbiobank.org100–10002008ICD-10n/aYes≤3 monthsNo
Arianna databaseItalyn/a10–1002002ICD-9n/aPilotn/aYes
4SGI-RVBSpainwww.csisp.gva.es/web/csisp10–1002010SNOMED (CT)Read CodesYes≤3 monthsYes
SIDIAPSpainn/a>50002005ICD-10n/aNo≤3 monthsNo
5The Wellcome Trust Type 2 Diabetes Genetics Case-control CollectionUK-Scotlandwww.diabetesgenetics.dundee.ac.uk10–1002004n/an/aYes≤3 monthsYes
Health Informatics CentreUK-Scotlandn/a100–10001990ICD-10SNOMEDYes≤3 monthsYes